Applications · EU
Basecamp Research was valued at $800M as of 23 September 2026 (verified). Source: Basecamp Research raises $140M to advance AI-designed therapeutics - oversubscribed Series C led by S32, with NVIDIA, Anthropic's Anthology Fund, Catalio, the NATO Innovation Fund, Rockefeller, Redalpine, Singular, Sovereign AI and True Ventures (company release).
London biodiversity-AI company (founded 2019) that designs therapeutics from nature's own protein space.
London biodiversity-AI company (founded 2019) that designs therapeutics from nature's own protein space. Its Trillion Gene Atlas - assembled from access-and-benefit-sharing partnerships in more than 30 countries and built with NVIDIA, Anthropic, PacBio and Ultima Genomics - trains the EDEN family of biological foundation models. The $140M Series C funds a new EDEN generation and pushes an AI-designed pipeline focused on in vivo cell therapy toward the clinic; total raised is about $225M.
See something wrong or out of date? Suggest a correction (GitHub) or email it. Please include a source.
Last updated 23 September 2026. Follow Basecamp Research in any feed reader to hear when its valuation moves.
State of AI World maps every significant AI company, what it is worth and how it is connected. Every number carries a source and an as-of date; see the methodology. Data is free to reuse with credit: open data. · All companies · Daily digest · Corrections and contact